Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMT2 | O60551 | 12/20 | 0.61 |
| ▸ | NMT1 | P30419 | 12/20 | 0.61 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.61 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.61 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6871630 | 0.96 | NMT2 (0.61) | NMT2NMT1ADRB2ADRB1ADRB3 | |
| SCHEMBL6870862 | 0.90 | NMT2 (0.62) | NMT2NMT1ADRB2ADRB1ADRB3 | |
| SCHEMBL6868394 | 0.85 | NMT2 (0.71) | NMT2NMT1ADRB2ADRB1ADRB3 | |
| SCHEMBL6870237 | 0.85 | NMT2 (0.70) | NMT2NMT1ADRB2ADRB1ADRB3 | |
| SCHEMBL3471346 | 0.84 | NMT2 (0.78) | NMT2NMT1ADRB2ADRB1ADRB3 | |
| SCHEMBL6868285 | 0.84 | NMT2 (0.72) | NMT2NMT1ADRB2ADRB1ADRB3 | |
| SCHEMBL6873855 | 0.82 | NMT2 (0.54) | NMT2NMT1ADRB2ADRB1ADRB3 | |
| SCHEMBL3477378 | 0.80 | NMT2 (0.78) | NMT2NMT1ADRB2ADRB1ADRB3 | |
| SCHEMBL3472745 | 0.77 | NMT2 (0.78) | NMT2NMT1ADRB2ADRB1ADRB3 | |
| SCHEMBL6871813 | 0.76 | NMT2 (1.00) | NMT2NMT1ADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1149094-B1 | 4-(AMINOALKOXY)BENZOFURANS AS N-MYRISTOYLTRANSFERASE INHIBITORS | BASILEA PHARMACEUTICA AG (CH) | 2004-04-21 | — | — | EP | claimed |